Episodic Cluster Headache
9
0
0
4
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
22.2%
2 terminated out of 9 trials
66.7%
-19.8% vs benchmark
78%
7 trials in Phase 3/4
75%
3 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Pulsed Radiofrequency Combined With Platelet-Rich Plasma Applied to the Sphenopalatine Ganglion in Treating Episodic Cluster Headache
A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache
A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)
Civamide Nasal Solution for Cluster Headache
A Study Of Galcanezumab In Participants With Episodic Cluster Headache
R-Verapamil for the Prophylaxis of Episodic Cluster Headache
A Phase III Study of Civamide Nasal Solution (Zucapsaicin) for the Treatment of Episodic Cluster Headache
Intranasal Civamide for Episodic Cluster Headache
Sumatriptan 4 mg Statdose in the Acute Treatment of Cluster Headache